MLL TRANSLOCATIONS SPECIFY A DISTINCT GENE EXPRESSION PROFILE, DISTINGUISHING A UNIQUE LEUKEMIA

Details for Australian Patent Application No. 2002354941 (hide)

Owner WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH DANAFARBER CANCER INSTITUTE, INC.

Inventors GOLUB, Todd, R.; KORSMEYER, Stanley, J.; ARMSTRONG, Scott, A.

Pub. Number AU-A-2002354941

PCT Number PCT/US02/22823

PCT Pub. Number WO2003/008552

Priority 60/306,103 17.07.01 US

Filing date 17 July 2002

Wipo publication date 3 March 2003

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): 60/306,103 17.07.01 US

22 May 2003 Application Open to Public Inspection

  Published as AU-A-2002354941

8 April 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002354942-METHODS FOR TREATING NEOPLASTIC, ANGIOGENIC, FIBROPLASTIC, AND/OR IMMUNOSUPPRESIVE OCULAR IRREGULARITIES VIA ADMINISTRATION OF METHOTREXATE BASED MEDICAMENTS, AND OCULAR IONTOPHORETIC DEVICES FOR DELIVERING METHOTREXATE BASED MEDICAMENTS

2002354940-A HARD SURFACE CLEANING COMPOSITION COMPRISING A SOLVENT SYSTEM